The Leukemia & Lymphoma Society® (LLS) is the global leader in the fight against blood cancer. The LLS mission is to cure blood cancer and improve the quality of life of all patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. 
 
Founded in 1949 and headquartered in Rye Brook, NY, LLS has regions throughout the United States and Canada.

The University of Melbourne is Australia’s leading collaborative institution, and our reputation is grounded in our outstanding contributions to research.

We influence policy, create culturally significant works, challenge our understanding of the world around us and drive new technology to improve the health and wellbeing of our people and planet.

Our research is a global magnet for prospective students, graduate researchers, academics and partners. We work across seven campuses and three innovation precincts including the Southbank Arts Precinct, Melbourne Connect and the Melbourne Biomedical Precinct. Currently we are actively working on 5,000 externally funded research projects in a range of fields including Indigenous knowledge, human rights law, quantum computing, vaccine development, and fine arts.

One way or another, cancer touches all our lives. Which is why nothing is more personal, or more urgent, than our goal to find cures for cancer and to deliver on our purpose: breakthroughs that change patients’ lives.

Teen Cancer America partners with cancer centers and hospitals across the United States interested in developing programs targeted at improving the care and outcomes of adolescents and young adults (AYA) diagnosed with cancer. This population faces unique challenges with cancer, its treatment, and survivorship due to their age and transitional stages in life. Cancer disrupts these critical years, derailing the defining journey into adulthood. We bring our experience and expertise in building comprehensive AYA programs, collaborating with each site to create a tailored approach that meets the unique needs of the site’s AYAs and clinicians, leveraging existing services and resources within the treatment center, while integrating community resources.

Australian made and owned, MooGoo Skin Care was founded in 2005 and has since grown to over 40 products to help with different skin and scalp problems.  MooGoo’s ingredient philosophy has always remained the same: “To make effective products using healthy natural ingredients that we are comfortable using on ourselves and loved ones”. 

Alexion, Astra Zeneca Rare Diseases, has been a leader in rare diseases for 30 years. Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialisation of life-changing medicines. We work alongside healthcare providers, patient advocacy organisations and governments to best serve patients by innovating and expanding our knowledge of rare diseases. Our goal is to bring hope to patients and families by delivering scientific advances.

The Youth Cancer Service (YCS) provides treatment and support for young people with cancer aged 15 to 25 and is based in based in major hospitals throughout Australia. More than 1,000 Australians aged 15 to 25 are diagnosed with cancer every year and approximately 75% of newly diagnosed young cancer patients are now being treated and supported through the YCS. Adolescents and young adults with cancer (‘AYAs’) have unique and complex medical and psychosocial needs, distinct from those of paediatric and older adult patients. Specialised AYA care is an essential component of optimal cancer care pathways for young people. Tailored care gives young people the very best chance of survival and helps manage the immediate and long-term impacts of AYA cancer on individuals, families, communities, health systems and economies. Dedicated, multi-disciplinary YCS teams deliver specialist, coordinated medical and psychosocial care and support to AYAs across Australia. They use a flexible, multidisciplinary team-based approach that considers and provides for the needs of young people and families across the disease trajectory from diagnosis, through treatment to survivorship and palliative care. In the 14 years since the first specialised YCS opened its doors we have seen survival rates increase to 90%. 

In 2015, Canteen Australia, UK’s Teenage Cancer Trust, and Teen Cancer America, formed the AYA Cancer Global Accord. Adolescents and young adults (AYAs) with cancer have unique and complex medical and psychosocial needs, distinct from those of paediatric and older adult patients, and as such, require tailored, specialised AYA cancer care. The aim of the Accord is to invest and support a growing multidisciplinary workforce who are committed to improving the lives of AYAs diagnosed with cancer, worldwide. A key focus of this partnership is the Annual Global AYA Cancer Congress Series, hosted on a rotating basis by the foundational partner organisations. Together these organisations have created the first truly global congress in AYA cancer care, where speakers from across the globe gather to present sector-leading research on cancer care for young people, helping to improve treatment and care around the world. The Congress provides health and social care professionals a unique opportunity to network and share information about this specialist area of cancer care, and to learn from leading national and international specialists in their respective disciplines.